Literature DB >> 26450466

Recidivism in Liver Transplant Recipients With Alcoholic Liver Disease: Analysis of Demographic, Psychosocial, and Histology Features.

Sanjaya K Satapathy1, James D Eason, Satheesh Nair, Oleksandra Dryn, Pamela B Sylvestre, Mehmet Kocak, Jason M Vanatta.   

Abstract

OBJECTIVES: Liver transplant for alcoholic liver disease requires identifying potential recipients at risk for recidivism. We sought to identify risk factors for recidivism and survival in recipients of liver transplant with alcoholic liver disease.
MATERIALS AND METHODS: Demographic, psychosocial, and histology features were evaluated as risk factors toward harmful recidivism in 148 recipients of liver transplant with alcoholic liver disease.
RESULTS: Based on the univariate analysis using Cox proportional hazards model, duration of alcohol abstinence 6 months (HR 3.74; P = .011, 95% CI: 1.36-10.3), non-alcohol related criminal history (HR 3.18; P = .032, 95% CI: 1.1-9.15), support from immediate family (HR 0.24; P = .0061, 95% CI: 0.09-0.67), and active smoking at the time of liver transplant (HR 2.74; P = .041, 95% CI: 1-7.53) were identified as significant predictors for recidivism. Older patients had less likelihood of alcohol relapse (HR 0.91; P = .0014, 95% CI: 0.87-0.97) on univariate model. In multivariate model older patients (HR 0.91; P = .004, 95% CI: 0.86-0.97) and patients who have immediate family support (HR 0.27; P = .012, 95% CI: 0.10-0.76) predicated against recidivism. Suggestive features of alcoholic hepatitis on liver explant did not predict recidivism or long-term survival. One-, three-, and five-year patient survival rates estimated by Kaplan-Meier survival model in the recipients that remained abstinent were 95%, 87%, and 80%, compared with 87%, 49%, and 49% for the recipients with recidivism (P = .001).
CONCLUSIONS: Recidivism is associated with earlier death after liver transplant. Older recipients and patients with immediate family support are less likely to have alcohol relapse, and have better long-term survival.

Entities:  

Mesh:

Year:  2015        PMID: 26450466

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  7 in total

1.  Incidence of and Risk Factors for Alcohol Relapse After Liver Transplantation for Alcoholic Liver Disease: Comparison Between Deceased Donor and Living Donor Liver Transplantation.

Authors:  Hye Gyo Chung; Dong Hyun Sinn; Wonseok Kang; Gyu-Seong Choi; Jong Man Kim; Jae-Won Joh
Journal:  J Gastrointest Surg       Date:  2020-02-24       Impact factor: 3.452

Review 2.  Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Naveen Kumar; Sanjiv Saigal; Rahul Rai; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

Review 3.  Recidivism in Liver Transplant Recipients for Alcohol-related Liver Disease.

Authors:  Narendra S Choudhary; Neeraj Saraf; Saurabh Mehrotra; Sanjiv Saigal; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2020-09-06

4.  Poor Outcomes after Recidivism in Living Donor Liver Transplantation for Alcohol-Related Liver Disease.

Authors:  Narendra S Choudhary; Neeraj Saraf; Swapnil Dhampalwar; Sanjiv Saigal; Dheeraj Gautam; Amit Rastogi; Prashant Bhangui; Thiagrajan Srinivasan; Vipul Rastogi; Saurabh Mehrotra; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2021-05-06

Review 5.  Risk factors and outcomes associated with alcohol relapse after liver transplantation.

Authors:  Jane Lim; Michael P Curry; Vinay Sundaram
Journal:  World J Hepatol       Date:  2017-06-18

6.  Alcohol relapse and its predictors after liver transplantation for alcoholic liver disease: a systematic review and meta-analysis.

Authors:  Lancharat Chuncharunee; Noriyo Yamashiki; Ammarin Thakkinstian; Abhasnee Sobhonslidsuk
Journal:  BMC Gastroenterol       Date:  2019-08-22       Impact factor: 3.067

7.  Factors Having an Impact on Relapse and Survival in Transplant Recipients With Alcohol-Induced Liver Disease.

Authors:  Terry D Schneekloth; Juan P Arab; Douglas A Simonetto; Tanya M Petterson; Shehzad K Niazi; Daniel K Hall-Flavin; Victor M Karpyak; Bhanu P Kolla; James E Roth; Walter K Kremers; Charles B Rosen
Journal:  Mayo Clin Proc Innov Qual Outcomes       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.